{"id":8121,"date":"2024-01-21T04:57:49","date_gmt":"2024-01-20T23:27:49","guid":{"rendered":"https:\/\/indianpharmanetwork.co.in\/medicines\/?post_type=product&#038;p=8121"},"modified":"2024-10-04T17:07:54","modified_gmt":"2024-10-04T11:37:54","slug":"sarclisa-price-india","status":"publish","type":"product","link":"https:\/\/indianpharmanetwork.co.in\/medicines\/product\/sarclisa-price-india\/","title":{"rendered":"SARCLISA (isatuximab-irfc) Injection"},"content":{"rendered":"<h4><strong>Generic Name: isatuximab-irfc Brand Name: SARCLISA<\/strong><br \/>\nSARCLISA is a CD38-directed cytolytic antibody indicated, in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma.<\/h4>\n<h4>What letermovir is and used for?<\/h4>\n<p class=\"lh-sm small fst-italic\">Isatuximab, sold under the brand name Sarclisa, is a monoclonal antibody (mAb) medication for the treatment of multiple myeloma. In the United States it is indicated, in combination with pomalidomide and dexamethasone, for the treatment of adults with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor. It is also indicated in combination with carfilzomib and dexamethasone, for the treatment of adults with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy.<\/p>\n<p class=\"lh-sm small fst-italic\">In the European Union it is indicated, in combination with pomalidomide and dexamethasone, for the treatment of adults with relapsed and refractory multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (PI) and have demonstrated disease progression on the last therapy.<\/p>\n<h4>How can 1 go about obtaining SARCLISA Injection?<\/h4>\n<p>If <strong>SARCLISA (isatuximab-irfc) Injection\u00a0<\/strong>are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n<p><strong>Note:<\/strong><br \/>\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n<p><strong>NEWS \/ UPDATES<\/strong><\/p>\n<ul>\n<li class=\"lh-sm small fst-italic\">For SARCLISA (isatuximab-irfc)Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions\u00a0<a class=\"text-decoration-none\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761113s000lbl.pdf\" target=\"_blank\" rel=\"noopener\">For More Details\u00a0<i class=\"fa fa-angle-double-right\"><\/i><\/a><\/li>\n<li class=\"lh-sm small fst-italic\">FDA approves isatuximab-irfc for multiple myeloma\u00a0<a class=\"readmore\" href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-isatuximab-irfc-multiple-myeloma\" target=\"_blank\" rel=\"noopener\">For More Details\u00a0<i class=\"fa fa-angle-double-right\"><\/i><\/a><\/li>\n<li class=\"lh-sm small fst-italic\">FDA Approves Isatuximab, Carfilzomib, Dexamethasone Combination for RRMM\u00a0<a href=\"https:\/\/www.ajmc.com\/view\/fda-approves-isatuximab-carfilzomib-dexamethasone-combination-for-rrmm\" target=\"_blank\" rel=\"noopener\">For More Details\u00a0<i class=\"fa fa-angle-double-right\"><\/i><\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<h2 class=\"display-6 mb-2 text-white lh-1\">SARCLISA (isatuximab-irfc) injection<\/h2>\n<p>SARCLISA is a CD38-directed cytolytic antibody indicated, in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor<br \/>\nIf you have any questions about your illness, talk to your doctor<br \/>\nSource Details:\u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761113s000lbl.pdf\" target=\"_blank\" rel=\"noopener\">Patient Information<\/a><\/p>\n<h4>Access Patient Name Basis Treatment<\/h4>\n<p>If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0<a href=\"https:\/\/indianpharmanetwork.co.in\/about-ipn.php\">IPN<\/a>\u00a0in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely<strong> import SARCLISA (isatuximab-irfc) Injection\u00a0\u201d ba<\/strong>sed on the information you provide.<\/p>\n<p><strong><a href=\"https:\/\/indianpharmanetwork.co.in\/about-ipn.php\">Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a><\/strong>. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as\u00a0<strong>Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik,<\/strong>\u00a0and various other regions in India.<\/p>\n","protected":false},"featured_media":8149,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"product_brand":[],"product_cat":[156],"product_tag":[265,264],"class_list":{"0":"post-8121","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-uncategorized","7":"product_tag-isatuximab-irfc","8":"product_tag-sarclisa","10":"first","11":"instock","12":"shipping-taxable","13":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/8121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/8149"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=8121"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=8121"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=8121"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=8121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}